Studies from U.
Our news editors obtained a quote from the research, "We focused on the role of patient co-morbidity-which would be a medical explanation for adopting TAVI-and hospital ownership status, hypothesizing that for-profit facilities are more likely to capitalize on the favorable reimbursement conditions of TAVI. The analysis uses claims data from the Techniker Krankenkasse, the largest health insurance fund in
According to the news editors, the research concluded: "Overall, the effects of co-morbidity suggest that providers acted responsibly when adopting TAVI while evidence was still emerging."
For more information on this research see: The Choice of Transcatheter Aortic Valve Implementation (TAVI): Do Patient Co-morbidity and Hospital Ownership Type Matter? Applied Health Economics and Health Policy, 2018;16(5):735-744. Applied Health Economics and Health Policy can be contacted at: Springer International Publishing Ag, Gewerbestrasse 11, Cham, Ch-6330,
The news editors report that additional information may be obtained by contacting U.
The direct object identifier (DOI) for that additional information is: https://doi.org/10.1007/s40258-018-0414-6. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
Keywords for this news article include:
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC